illustration of woman presenting company pitch to JPM Healthcare investors

The “Forcing Function” of JPM

Biopharma companies need to balance many critical priorities, especially those…

Connecting in a Volatile Job Market

What is the correct metaphor for today’s biopharma job market? A…

A Practical Guide to Biopharma Year-End Planning

As summer winds down and vacations (sadly) come to an end, it’s a natural time…

Building Credibility as a New Leader

Credibility is essential for leaders in any industry, but in the high-stakes…

Unfinished Business on the Glass Ceiling

Reflecting on my career and the significant societal and technological shifts during those years, I see it as split between two generations, each…

Governance: The Glue to a Successful Launch

At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert management of its execution.

Image of a pharmacist looking into an overlay of biopharma data thinking about strategy

Your Biopharma Data Needs a Strategy

In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for the purposes of drug development…

Success in Rare Disease: Patient Involvement Matters!

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the Development of Drugs…

Juggling Geographic Commercialization Priorities

Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is exponentially…

Happy Anniversary to Us!

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the…

Hybrid Work Strategies: 3 Tips to Transform Engagement

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…

pipeline-medical-affairs-an-orchestra-not-a-horse-race

Medical Affairs: An Orchestra, Not a Horse Race

Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar.…

Three Big Mistakes

Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic…

What’s the Latest?

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…